Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise
Executive Summary
Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.
You may also be interested in...
Dermapharm Expands Natural Offering With France's Arkopharma
Germany's Dermapharm will pay €450m to acquire herbal specialist Arkopharma to expand its footprint in Europe's consumer health market in countries such as France, Spain and Italy.
Bayer Extends Personalized Health Offering With At-Home Biological Age Test
Advancing personalized consumer innovation in healthy aging is the goal of a new partnership between Bayer and biological age test development firm Hurdle.
Stada Grows China Presence Through CR Sanjiu Partnership
Stada has struck a deal with CR Sanjiu for distribution and promotion of its cough and cold brands after identifying expansion in the Chinese market as a key strategic target.